Haematology Donation: CML Therapeutic Review Audit Service Donation
Translating new guidelines and best practice sharing into improved patient care.
In 2020, the British Society for Haematology (BSH) published guidelines on the diagnosis and management of Chronic Myeloid Leukaemia (CML). To support the implementation of this UK ‘gold standard’ patient care, Pfizer has developed an audit tool and trained a group of skilled nurses to aid NHS hospitals auditing their CML service. The aim of this service donation is to translate new guidelines and best practice sharing into improved patient care.
The CML therapy review audit service will include the following aspects:
- A digital Excel audit tool based on BSH 2020 CML guidelines for the collection of data. This audit tool will be uploaded to the selected NHS hospital’s computer and, on completion of the audit, will belong to that NHS hospital. The audit tool has been built to include data analytics outputs.
- A trained and qualified audit nurse will be provided by a third-party contractor, IQVIA. The nurse will audit a maximum of 40 patients within each selected NHS hospital.
- A final presentation on how closely the audited hospital’s CML service adheres to the 2020 BSH CML guidelines will be delivered by the trained audit nurse.
All NHS hospitals within the UK are permitted to apply for this service donation. Seven NHS hospitals in total will be selected to receive this donation on a first-come, first-served basis and based on the below criteria:
- A minimum of 40 CML patients being treated within the NHS hospital is required
- At least one member of the hospital team dedicated to helping facilitate the audit
- No internal hospital audits completed using the BSH CML guidelines since 2020
- No contributing authors to the BSH CML guidelines directing CML patient care within haematology department at present (this point does not completely exclude application but will be considered as part of the broader application)
- NHS hospital shows commitment to completing audit in a timely manner
- NHS hospital commits to re-auditing their service within a 12-month time period, independent of any service donation or financial support from Pfizer
- NHS hospital expresses intent to share best practice via local or national publication/congress presentation
PLEASE DO NOT APPLY FOR THIS DONATION IF YOUR NHS HOSPITAL CANNOT MEET THE MAJORITY OF THE REQUIRED CRITERIA. On submission of a donation request form, via the link at the bottom of this page, a formal 250-word eligibility application will also be required. Details of this additional information will follow your submission.
It’s important to note that Pfizer will not have access to, nor will Pfizer be privy to, any data collected during the audit. Patient confidentially will be strictly maintained. The audit tool will be uploaded to the hospital NHS computer by the third-party nurse assisting with the audit and the audit tool will always remain on that NHS computer. No data will be removed from the hospital and, on completion of the audit and final presentation of data analytics, the audit tool will remain under the hospital’s possession.
Third-party nurses will be employed on a temporary honorary contract with each NHS hospital that receives this donation. The nurses will require access to NHS computers and working space, alongside medical notes if needed.
All applications will be reviewed in order of application date and time on a first-come, first-served basis. Once all donation funding has been allocated then the application portal will close. If a large number of applications are received all at once then the application portal may close until the backlog of applications is reviewed or until all donations are allocated, whichever occurs first.
All applications will be reviewed by an internal Pfizer medical review panel. Additional clarification during the review period may be requested. All applicants will be notified via email regarding the outcome of their request, upon completion of the internal review process.
If your application is approved, your institution will be required to enter into a written agreement with Pfizer. In the event of a successful application, core terms of the agreement will be provided at a later date. Disclosure of this Pfizer funded donation will be required by each recipient hospital.